Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT05712967
Eligibility Criteria:
Inclusion Criteria:
patients fulfilling the International Myeloma Working Group (IMWG) diagnostic criteria for SMM or MM, and 10 healthy controls older than 18 years and accepting to sign the informed consent
Exclusion Criteria:
* Non-Caucasian subjects.
* Subjects younger than 18 years.
* Subjects that did not accept to sign the informed consent.
* Subjects reporting infectious diseases requiring antibiotic therapy in the previous three months, ongoing antibiotic therapy or prophylaxis.
* Subjects who already underwent HSCT or under pharmacologic therapy for MM.
* Subjects affected by autoimmune diseases with the exception of thyroiditis.
* Subjects affected by HIV, HBV or HCV.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05712967
Study Brief:
Protocol Section:
NCT05712967